159 related articles for article (PubMed ID: 30911053)
1. SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study.
Polzik P; Grøndal O; Tavenier J; Madsen MB; Andersen O; Hedetoft M; Hyldegaard O
Sci Rep; 2019 Mar; 9(1):5098. PubMed ID: 30911053
[TBL] [Abstract][Full Text] [Related]
2. Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine With Morbidity and Mortality in Patients With Necrotizing Soft Tissue Infections.
Hansen MB; Rasmussen LS; Garred P; Pilely K; Wahl AM; Perner A; Madsen MB; Hedegaard ER; Simonsen U; Hyldegaard O
Shock; 2018 Jun; 49(6):667-674. PubMed ID: 28863028
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
Hansen MB
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
[TBL] [Abstract][Full Text] [Related]
4. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.
Hansen MB; Rasmussen LS; Garred P; Bidstrup D; Madsen MB; Hyldegaard O
Crit Care; 2016 Feb; 20():40. PubMed ID: 26880104
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor.
Giamarellos-Bourboulis EJ; Norrby-Teglund A; Mylona V; Savva A; Tsangaris I; Dimopoulou I; Mouktaroudi M; Raftogiannis M; Georgitsi M; Linnér A; Adamis G; Antonopoulou A; Apostolidou E; Chrisofos M; Katsenos C; Koutelidakis I; Kotzampassi K; Koratzanis G; Koupetori M; Kritselis I; Lymberopoulou K; Mandragos K; Marioli A; Sundén-Cullberg J; Mega A; Prekates A; Routsi C; Gogos C; Treutiger CJ; Armaganidis A; Dimopoulos G
Crit Care; 2012 Aug; 16(4):R149. PubMed ID: 22873681
[TBL] [Abstract][Full Text] [Related]
6. The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock.
Turan C; Yurtseven A; Ozkaya PY; Azarsiz E; Saz EU
J Clin Lab Anal; 2024 May; 38(9):e25040. PubMed ID: 38708489
[TBL] [Abstract][Full Text] [Related]
7. How biomarkers reflect the prognosis and treatment of necrotising soft tissue infections and the effects of hyperbaric oxygen therapy: the protocol of the prospective cohort PROTREAT study conducted at a tertiary hospital in Copenhagen, Denmark.
Polzik P; Johansson PI; Hyldegaard O
BMJ Open; 2017 Oct; 7(10):e017805. PubMed ID: 28982834
[TBL] [Abstract][Full Text] [Related]
8. Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit.
Reisinger AC; Niedrist T; Posch F; Hatzl S; Hackl G; Prattes J; Schilcher G; Meißl AM; Raggam RB; Herrmann M; Eller P
Sci Rep; 2021 Sep; 11(1):17476. PubMed ID: 34471146
[TBL] [Abstract][Full Text] [Related]
9. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
[TBL] [Abstract][Full Text] [Related]
10. Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.
Geboers DG; de Beer FM; Tuip-de Boer AM; van der Poll T; Horn J; Cremer OL; Bonten MJ; Ong DS; Schultz MJ; Bos LD
Intensive Care Med; 2015 Jul; 41(7):1281-90. PubMed ID: 26100127
[TBL] [Abstract][Full Text] [Related]
11. Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study.
Hansen MB; Rasmussen LS; Svensson M; Chakrakodi B; Bruun T; Madsen MB; Perner A; Garred P; Hyldegaard O; Norrby-Teglund A;
Sci Rep; 2017 Feb; 7():42179. PubMed ID: 28176831
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
[TBL] [Abstract][Full Text] [Related]
13. Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study.
Haupt TH; Petersen J; Ellekilde G; Klausen HH; Thorball CW; Eugen-Olsen J; Andersen O
Crit Care; 2012 Jul; 16(4):R130. PubMed ID: 22824423
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin induces soluble urokinase-type plasminogen activator receptor production and release.
Vaschetto R; Navalesi P; Clemente N; Boggio E; Valsecchi S; Olivieri C; Soluri MF; Kroumova V; Fonio P; Dinatale C; Borrè S; Fortina G; Umberto D; Della Corte F; Chiocchetti A
Minerva Anestesiol; 2015 Feb; 81(2):157-65. PubMed ID: 24994498
[TBL] [Abstract][Full Text] [Related]
15. Blood suPAR, Th1 and Th17 cell may serve as potential biomarkers for elderly sepsis management.
Zhao L; Yu S; Wang L; Zhang X; Hou J; Li X
Scand J Clin Lab Invest; 2021 Oct; 81(6):488-493. PubMed ID: 34369213
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study.
Liu X; Shen Y; Li Z; Fei A; Wang H; Ge Q; Pan S
BMC Anesthesiol; 2016 Jul; 16(1):46. PubMed ID: 27473112
[TBL] [Abstract][Full Text] [Related]
17. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.
Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T
J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143
[TBL] [Abstract][Full Text] [Related]
18. Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections-A Prospective Observational Study.
Kristensen MK; Hansen MB; Madsen MB; Hansen CB; Pilely K; Hyldegaard O; Garred P
Front Immunol; 2020; 11():17. PubMed ID: 32082310
[No Abstract] [Full Text] [Related]
19. Thrombo-inflammatory biomarkers to predict sepsis outcome.
Efat A; Shoeib SA; Arafa AF; Dawod AA; Abd ElHafez MA; Abd ElMohsen EA; Eladly HF; Ibrahim RA; Elkholy A
Int J Immunopathol Pharmacol; 2021; 35():20587384211048561. PubMed ID: 34647483
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.
Hua C; Sbidian E; Hemery F; Decousser JW; Bosc R; Amathieu R; Rahmouni A; Wolkenstein P; Valeyrie-Allanore L; Brun-Buisson C; de Prost N; Chosidow O
J Am Acad Dermatol; 2015 Dec; 73(6):1006-12.e8. PubMed ID: 26412163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
